BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29615722)

  • 1. Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS.
    Lima AR; Araújo AM; Pinto J; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes de Pinho P
    Sci Rep; 2018 Apr; 8(1):5539. PubMed ID: 29615722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
    Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
    Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
    Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of extracellular metabolome by HS-SPME/GC-MS: Optimization and application in a pilot study to evaluate galactosamine-induced hepatotoxicity.
    Araújo AM; Moreira N; Lima AR; Bastos ML; Carvalho F; Carvalho M; Guedes de Pinho P
    Toxicol Lett; 2018 Oct; 295():22-31. PubMed ID: 29852275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells.
    Lima AR; Araújo AM; Pinto J; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes de Pinho P
    Metabolites; 2018 Mar; 8(1):. PubMed ID: 29562689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New findings on urinary prostate cancer metabolome through combined GC-MS and
    Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
    Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furan and p-xylene as candidate biomarkers for prostate cancer.
    Jiménez-Pacheco A; Salinero-Bachiller M; Iribar MC; López-Luque A; Miján-Ortiz JL; Peinado JM
    Urol Oncol; 2018 May; 36(5):243.e21-243.e27. PubMed ID: 29395956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
    Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
    Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted Metabolomic Profile for the Detection of Prostate Carcinoma-Preliminary Results from PARAFAC2 and PLS-DA Models.
    Amante E; Salomone A; Alladio E; Vincenti M; Porpiglia F; Bro R
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31443574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.
    Tyagi H; Daulton E; Bannaga AS; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers.
    Lubes G; Goodarzi M
    J Pharm Biomed Anal; 2018 Jan; 147():313-322. PubMed ID: 28750734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile biomarkers from human melanoma cells.
    Kwak J; Gallagher M; Ozdener MH; Wysocki CJ; Goldsmith BR; Isamah A; Faranda A; Fakharzadeh SS; Herlyn M; Johnson AT; Preti G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():90-6. PubMed ID: 23770738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
    Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
    PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Serum Metabolomic Profiling Reveals Elevated Kynurenine Pathway's Metabolites in Humans with Prostate Cancer.
    Khan A; Choi SA; Na J; Pamungkas AD; Jung KJ; Jee SH; Park YH
    J Proteome Res; 2019 Apr; 18(4):1532-1541. PubMed ID: 30628444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatile metabolomic signature of human breast cancer cell lines.
    Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
    Sci Rep; 2017 Mar; 7():43969. PubMed ID: 28256598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.
    Hormaechea-Agulla D; Gahete MD; Jiménez-Vacas JM; Gómez-Gómez E; Ibáñez-Costa A; L-López F; Rivero-Cortés E; Sarmento-Cabral A; Valero-Rosa J; Carrasco-Valiente J; Sánchez-Sánchez R; Ortega-Salas R; Moreno MM; Tsomaia N; Swanson SM; Culler MD; Requena MJ; Castaño JP; Luque RM
    Mol Cancer; 2017 Aug; 16(1):146. PubMed ID: 28851363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of characteristic metabolites of Aspergillus fumigatus and Candida species using ion mobility spectrometry-metabolic profiling by volatile organic compounds.
    Perl T; Jünger M; Vautz W; Nolte J; Kuhns M; Borg-von Zepelin M; Quintel M
    Mycoses; 2011 Nov; 54(6):e828-37. PubMed ID: 21668516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.